Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Concert Pharmaceuticals' Shares Slip Despite Favorable FDA Meeting
Concert Pharmaceuticals' Shares Slip Despite Favorable FDA Meeting
Concert Pharmaceuticals' Shares Slip Despite Favorable FDA Meeting
Submitted by
admin
on July 9, 2014 - 11:50am
Source:
Yahoo/Zacks.com
News Tags:
Concert Pharmaceuticals
FDA
CTP-499
diabetic nephropathy
Headline:
Concert Pharmaceuticals' Shares Slip Despite Favorable FDA Meeting
Do Not Allow Advertisers to Use My Personal information
